Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.4022/jafib.732 http://scihub22266oqcxt.onion/10.4022/jafib.732 C5153105!5153105!28496810     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Atr+Fibrillation 2013 ; 5 (5): ä Nephropedia Template TP {{tp|p=28496810|t=2013. Prevention of Stroke by Antithrombotic Therapy in Patients with Atrial Fibrillation |pdf=|usr=}}{{28496810}} gab.com Text Prevention of Stroke by Antithrombotic Therapy in Patients with Atrial Fibrillation JO: J Atr Fibrillation http://www.kidney.de/pget.php?&tw=1&pmid=28496810 #FOAvip Atrial Fibrillation (AF) is the most common clinically significant sustained cardiac arrhythmia, a major risk factor for strokes whether it is symptomatic or silent. The older CHADS2 score and the newer CHADS2-VASc are well validated to determine stroke risk and guide initiation of antithrombotic therapy, but haemorrhagic risk has to be respected as well, and scores such as HAS-BLED should be widely used. Old fashioned warfarin became standard of care outperforming antiplatelets in every trial but novel classes of anticoagulants that overcome many of warfarin drawbacks have been introduced and are already guideline recommended regiments. Nevertheless their use poses new questions that have to been answered in the near future. Twit Text FOAVip Prevention of Stroke by Antithrombotic Therapy in Patients with Atrial Fibrillation ????J Atr Fibrillation http://www.kidney.de/pget.php?&tw=1&pmid=28496810 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28496810 #FOAvip English Wikipedia <ref>{{Cite pmid|28496810}}</ref> Prevention of Stroke by Antithrombotic Therapy in Patients with Atrial Fibrillation #MMPMID28496810 Manolis AJ; Poulimenos LE J Atr Fibrillation 2013[Feb]; 5 (5): ä PMID28496810show ga Atrial Fibrillation (AF) is the most common clinically significant sustained cardiac arrhythmia, a major risk factor for strokes whether it is symptomatic or silent. The older CHADS2 score and the newer CHADS2-VASc are well validated to determine stroke risk and guide initiation of antithrombotic therapy, but haemorrhagic risk has to be respected as well, and scores such as HAS-BLED should be widely used. Old fashioned warfarin became standard of care outperforming antiplatelets in every trial but novel classes of anticoagulants that overcome many of warfarin drawbacks have been introduced and are already guideline recommended regiments. Nevertheless their use poses new questions that have to been answered in the near future. äPrevention of Stroke by Antithrombotic Therapy in Patients with Atrial(epmc).pdf DeepDyve Pubget Overpricing